Brief: Scisparc-Clearmind Medicine Collaboration Announces The Publication Of European Patent Application For Binge Behavior Psychedelic Combination Treatment
06/01/2025 13:00
Jan 6 (Reuters) - Clearmind Medicine Inc CMND.O :
* SCISPARC-CLEARMIND MEDICINE COLLABORATION ANNOUNCES THE
PUBLICATION OF EUROPEAN PATENT APPLICATION FOR BINGE BEHAVIOR
PSYCHEDELIC COMBINATION TREATMENT
Source text: urn:newsml:reuters.com:*:nGNXc5537N
Further company coverage: CMND.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearmind Medicine
See all newsBrief: Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM